These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30648989)

  • 21. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa.
    Delobeau M; Abdou A; Puzenat E; Deveza E; Biver-Dalle C; van de Laak A; Roche-Kubler B; Vuitton L; Koch S; Wendling D; Aubin F
    J Dermatolog Treat; 2016; 27(3):251-3. PubMed ID: 26368546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Henoch-Schönlein purpura during anti-TNFα therapy: a fortuitous event or an indication to stop therapy?
    Pinheiro RR; Lencastre A
    Eur J Dermatol; 2017 Jun; 27(3):304-305. PubMed ID: 28468732
    [No Abstract]   [Full Text] [Related]  

  • 23. A catastrophic vulvar ulcer.
    Prasad S; Mauskar MM
    Am J Obstet Gynecol; 2020 Mar; 222(3):276-277. PubMed ID: 31233709
    [No Abstract]   [Full Text] [Related]  

  • 24. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
    Haennig A; Bonnet D; Thebault S; Alric L
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
    [No Abstract]   [Full Text] [Related]  

  • 25. Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome.
    Cheemalavagu S; McCoy SS; Knight JS
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32041760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extra-pulmonary Reactivation of Latent Tuberculosis After Initiation of Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease-Are Current Screening Strategies Adequate?
    Tranah TH; Luk SY; Gess M
    J Crohns Colitis; 2017 Jun; 11(6):762-763. PubMed ID: 27932451
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease.
    Ogata H; Watanabe M; Matsui T; Hase H; Okayasu M; Tsuchiya T; Shinmura Y; Hibi T
    J Crohns Colitis; 2016 Sep; 10(9):1033-41. PubMed ID: 26961546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute lymphoid leukemia in a Crohn's disease patient during treatment with adalimumab after a prolonged treatment with azathioprine and steroids.
    Cesarini M; Vernia P; Angelucci E
    Inflamm Bowel Dis; 2010 Mar; 16(3):371-2. PubMed ID: 19637388
    [No Abstract]   [Full Text] [Related]  

  • 29. Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
    Holmstrøm RB; Mogensen DV; Brynskov J; Ainsworth MA; Nersting J; Schmiegelow K; Steenholdt C
    Dig Dis Sci; 2018 Jun; 63(6):1583-1591. PubMed ID: 29564674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rare case of malignant syphilis after adalimumab therapy due to Crohn's disease associated with bariatric surgery.
    Yıldızhan IK; Şanlı HE; Çetinkaya H; Akay BN; Koçyiğit P; Kundakçı N
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):89-92. PubMed ID: 31279583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.
    Petitpain N; Bornert-Keller N; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Oct; 7(9):e396. PubMed ID: 23523265
    [No Abstract]   [Full Text] [Related]  

  • 32. Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy.
    Sartini A; Scaioli E; Liverani E; Bellanova M; Ricciardiello L; Bazzoli F; Belluzzi A
    Dig Dis Sci; 2019 Mar; 64(3):863-874. PubMed ID: 30334112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tubulointerstitiel nephritis and Crohn's disease, nephrotoxicity or extraintestinal manifestation of Crohn's disease? About a case].
    Treffel M; Champigneulle J; Meibody F; Laurain E; Frimat L; Busby-Venner H
    Nephrol Ther; 2019 Mar; 15(1):59-62. PubMed ID: 30503098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease.
    Casanova MJ; Chaparro M; Valenzuela C; Cisneros C; Gisbert JP
    World J Gastroenterol; 2015 Feb; 21(7):2260-2. PubMed ID: 25717268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Listeria monocytogenes infection in Crohn's disease treated with adalimumab.
    Willson KJ; Jacob A; Shetti MP; Bhatia R; Yee K; Osler W
    Med J Aust; 2012 Oct; 197(8):466-7. PubMed ID: 23072245
    [No Abstract]   [Full Text] [Related]  

  • 36. Ventricular tachyarrhythmia after adalimumab therapy in a patient with Crohn's disease.
    Eder P; Lykowska-Szuber L; Krela-Kazmierczak I; Stawczyk-Eder K; Linke K
    Acta Gastroenterol Belg; 2013 Mar; 76(1):74-5. PubMed ID: 23650791
    [No Abstract]   [Full Text] [Related]  

  • 37. Adalimumab for the treatment of pediatric Crohn's disease.
    Nuti F; Fiorino G; Danese S
    Expert Rev Clin Immunol; 2015; 11(9):963-72. PubMed ID: 26211396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient menorrhagia without adalimumab discontinuation in a patient with Crohn's disease.
    Katsanos KH; Tsianos VE; Tsianos EV
    J Crohns Colitis; 2010 Sep; 4(3):348. PubMed ID: 21122527
    [No Abstract]   [Full Text] [Related]  

  • 39. Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's Disease.
    Lie MR; Kreijne JE; van der Woude CJ
    Inflamm Bowel Dis; 2017 Jan; 23(1):75-81. PubMed ID: 28002127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease.
    Salar A; Bessa X; Muñiz E; Monfort D; Besses C; Andreu M
    Gut; 2007 Aug; 56(8):1169-70. PubMed ID: 17344276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.